methyleugenol has been researched along with Innate Inflammatory Response in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
| Kiem, PV; Kim, YH; Minh, CV; Ngan, NT; Quang, TH; Song, SB; Tai, BH; Thao, NP | 1 |
| Chen, F; Huang, Y; Ling, X; Tan, X; Tang, F; Tang, Q; Zheng, X | 1 |
| Cho, GS; Choi, YK; Hwang, S; Kim, BW; Kim, HC; Kim, WK; Kim, YS; Lee, JC; Lim, JH | 1 |
4 other study(ies) available for methyleugenol and Innate Inflammatory Response
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
Anti-inflammatory and PPAR transactivational effects of secondary metabolites from the roots of Asarum sieboldii.
Topics: Anti-Inflammatory Agents; Asarum; Cyclooxygenase 2; Dose-Response Relationship, Drug; Furans; Hep G2 Cells; Humans; Inflammation; Magnetic Resonance Spectroscopy; Mass Spectrometry; NF-kappa B; Nitric Oxide Synthase Type II; Phenols; Plant Roots; PPAR alpha; Republic of Korea; Transcription, Genetic; Transcriptional Activation; Tumor Necrosis Factor-alpha | 2012 |
Inhibitory effect of methyleugenol on IgE-mediated allergic inflammation in RBL-2H3 cells.
Topics: Animals; Arachidonic Acid; beta-N-Acetylhexosaminidases; Cell Line, Tumor; Cell Respiration; Dinoprostone; Eugenol; Extracellular Signal-Regulated MAP Kinases; Hypersensitivity; Immunoenzyme Techniques; Immunoglobulin E; Inflammation; Interleukin-4; Leukotriene B4; Leukotriene C4; Mast Cells; Mutagens; Prostaglandin D2; Rats; Tumor Necrosis Factor-alpha | 2015 |
Methyleugenol reduces cerebral ischemic injury by suppression of oxidative injury and inflammation.
Topics: Animals; Anti-Inflammatory Agents; Brain Ischemia; Cells, Cultured; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Eugenol; Free Radicals; Glucose; Inflammation; Male; Neurons; Oxidative Stress; Oxygen; Rats; Rats, Sprague-Dawley; Superoxides | 2010 |